Who owns GALMED PHARMACEUTICALS LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Galmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Galmed Pharmaceuticals stock

Who bought or sold GALMED PHARMACEUTICALS LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Citadel Advisors 51k $71k 100% Sep 2025
 View chart
Two Sigma Investments 21k $29k 100% Sep 2025
 View chart
Two Sigma Securities 14k $10k 100% Dec 2025
 View chart
Jane Street 12k $9.1k 100% Dec 2025
 View chart
XTX Topco 11k $8.3k 100% Dec 2025
 View chart
UBS Group 1.8k $1.2k 88% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 900.00 $675.000000 100% Dec 2025
 View chart
TSFG 17.00 $0 0% Dec 2025
 View chart
SBI Securities 16.00 $12.000000 0% Dec 2025
 View chart
Federation des caisses Desjardins du Quebec 14.00 $10.999800 0% Dec 2025
 View chart
Wells Fargo & Company 9.00 $7.000200 0% Dec 2025
 View chart
Advisor Group Holdings 5.00 $3.000000 0% Dec 2025
 View chart
Hanson McClain Advisors 2.00 $2.000000 0% Dec 2025
 View chart
Dogwood Wealth Management 1.00 $1.000000 0% Dec 2025
 View chart
Zrc Wealth Management 1.00 $1.000000 0% Dec 2025
 View chart

Who sold out of Galmed Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Sontag Advisory Sep 2025 21.00 $29.001000
TD Waterhouse Canada Sep 2025 2.00 $3.000000